Prednisolone
๐ Related Subjects:
| Osteoporosis
โ ๏ธ Avoid exposure to shingles or chickenpox in patients lacking acquired immunity and taking steroids.
Always check the BNF link here before prescribing.
๐ Action
- Glucocorticoid effect with anti-inflammatory & immunosuppressive activity.
- Mild mineralocorticoid activity (fluid retention, BP effects).
๐ Indications
- ๐ฆ Autoimmune & inflammatory: Rheumatoid arthritis, Inflammatory bowel disease.
- ๐ฉธ Vasculitis: Giant cell arteritis (GCA), Polymyalgia rheumatica (PMR).
- ๐งช Renal: Minimal change disease, transplant rejection prevention.
- ๐งฌ Endocrine: Addisonโs disease (replacement therapy).
- ๐ซ Respiratory: Asthma, COPD exacerbations, pulmonary fibrosis.
๐ Dose (specify duration!)
- Typical adult dose: 5โ60 mg once daily, depending on indication.
- BNF starting point: usually 10โ20 mg once daily, taken in the morning after food.
- Giant Cell Arteritis: 1 mg/kg once daily while awaiting diagnostic confirmation.
- Polymyalgia Rheumatica: typically 15 mg once daily.
- Acute severe asthma: 40โ60 mg once daily (or divided) for 3โ10 days (โburst therapyโ).
- ๐ For long courses: co-prescribe Calcium + Vitamin D and a Bisphosphonate for bone protection.
๐ป Tapering Guidance
- ๐ No taper needed if treatment is <3 weeks at standard doses (risk of adrenal suppression is minimal).
- โ ๏ธ Taper required if:
- Used for >3 weeks, OR
- โฅ40 mg/day for >1 week, OR
- Recent repeated courses (esp. within 1 year), OR
- Evening dosing, OR
- Features of Cushingโs syndrome (suggesting suppression).
- ๐งช Tapering strategy: Gradually reduce dose to a physiological level (โ5โ7.5 mg prednisolone), then wean slowly over weeks to months depending on duration of use and clinical indication.
- ๐จ If patient becomes acutely unwell during taper (e.g. infection, surgery) โ may need to increase dose temporarily (โstress dosingโ).
โ๏ธ Interactions
- See full list in the BNF.
- โ ๏ธ Important: NSAIDs (โ ulcer risk), anticoagulants (altered INR), antidiabetics (โ glucose), live vaccines (risk of infection).
โ ๏ธ Cautions
- โณ Withdrawal must be gradual if used >3 weeks (risk of adrenal insufficiency).
- ๐ฉบ Consider adding a PPI for GI protection if combined with NSAIDs or at risk of PUD.
- ๐ Monitor: BP, blood glucose, weight, mood, and bone density.
โ Contraindications
- ๐ซ Untreated systemic infection (bacterial, viral, fungal, parasitic).
- ๐ซ Recent live vaccine administration.
โ ๏ธ Side Effects
- ๐งฌ Endocrine: Cushingoid features, adrenal suppression, steroid-induced diabetes.
- โค๏ธ Renal/CV: Hypertension, hypokalaemic alkalosis, oedema.
- ๐ง Neuropsychiatric: Insomnia, mood swings, psychosis.
- ๐ฝ๏ธ GI: Dyspepsia, gastritis, peptic ulcer disease โ PPI often indicated.
- ๐ฆด MSK: Osteoporosis, osteopenia, avascular necrosis, proximal myopathy.
- ๐๏ธ Eye: Cataracts, glaucoma.
- ๐ฉน Skin: Thinning, striae, easy bruising, moon face, buffalo hump.
- ๐ฆ Immunosuppression: Increased infection risk (esp. opportunistic infections, sepsis).